Optimizing Outcomes with LAI PrEP and ART

Target Audience

The educational design of this activity addresses the needs of infectious disease and HIV medicine MDs, NPs, and PAs, along with nurses and pharmacists involved in the treatment of patients with HIV.

Program Overview

Long-acting injectable (LAI) preexposure prophylaxis (PrEP) and antiretroviral therapy (ART) have transformed HIV prevention and care in the last several years, requiring clinicians to adjust decision-making practices and clinic protocols to provide and increase accessibility to these therapies. In this Interactive Showcase CME symposium, learners will review the latest LAI PrEP or ART data, appropriate clinical application, and optimal LAI clinic protocols with Drs. Paul Sax, Monica Gandhi, and Meredith Clement. Take a walk through our narrated LAI PrEP and ART poster gallery, hear faculty discuss nuances of LAI PrEP and ART use in clinical practice, and make decisions in a clinical case series. Learners will leave with a greater understanding of patient selection, approaches to unique clinical scenarios, and options to improve workflow protocols around LAI PrEP and ART.

Educational Objectives

After completing this activity, the participant should be better able to:

• Interpret the efficacy, safety, and patient preference data and incorporate these findings into patient-centered decision making
• Apply evidence-informed decision-making strategies to optimize selection, initiation, and monitoring of LAI PrEP and ART
• Implement and refine advanced clinical workflows to expand equitable access to LAI PrEP and ART

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact Information

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the pretest, pass the posttest with a 70% score or higher, and submit an evaluation form. 

Fee Information

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Integritas Communications adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Meredith E. Clement, MD, MHSc: Consulting Fees: ViiV Healthcare; Honoraria: Gilead Sciences, Inc., ViiV Healthcare; Research support (paid to institution)  Gilead Sciences, Inc., Merck & Co., ViiV Healthcare

Monica Gandhi MD, MPH: Nothing to disclose

Paul E. Sax, MD: Consulting Fees: Gilead Sciences, Inc., Merck & Co, ViiV Healthcare; Contracted Research: Gilead Sciences, Inc., ViiV Healthcare

The planners and managers at Integritas Communications and Global have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas Communications does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.